The rising interest in potent weight management has led to considerable investigation into novel treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has demonstrated positive results in patient trials, suggesting potential for considerable weight loss . Consequently , s